11-THY-02-EI: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III

Grants and Contracts Details

StatusFinished
Effective start/end date1/5/126/30/15

Funding

  • Eisai Incorporated: $98,440.00